PainTEQ enters 2026 positioned for a new era of market leadership, building on the momentum of its 2025 recapitalization led by Signet Healthcare Partners and Windham Capital Partners. With a board of directors that includes industry veterans Mike Sherman and Robert Kline, PainTEQ remains committed to redefining SI joint care through continuous product innovation and rigorous clinical validation.
New Clinical Leadership and Evidence Pipeline
Lalit Venkatesan has joined PainTEQ as SVP of Clinical Research to lead the strategic expansion of the company’s evidence-based portfolio. A recognized expert in trial design, Venkatesan will scale a robust clinical roadmap headlined by a landmark Randomized Controlled Trial (RCT) and several prospective studies. This investment reinforces PainTEQ’s trajectory as the primary alternative to traditional surgery, delivering superior patient outcomes and new, safe solutions for interventionalists.
Product Portfolio Expansion
PainTEQ is also accelerating its product pipeline, with plans to launch multiple new products over the next 12 months, beginning in Q1 2026.
“The work we’ve done since our recapitalization has placed PainTEQ in pole position for 2026,” said Shanth Thiyagalingam, CEO of PainTEQ. “With the team and strategy in place, we are deploying the resources to scale. Our presence at NANS, backed by forthcoming clinical initiatives and product launches, marks a significant new chapter for our company, for the tens of thousands of patients we serve, and for the hundreds of leading interventionalists we partner with.”
PainTEQ at NANS 2026
PainTEQ will host a series of events and engagement opportunities aimed at advancing education, clinical discussion, and collaboration within the interventional pain community during NANS 2026. Attendees can engage with the PainTEQ team and key opinion leaders at the following locations and events:
1. Visit the PainTEQ Booth
- Location: Booth #443 (NANS Exhibit Hall)
- Title: LinQ Real-World Evidence and Complex SIJF Case Presentation
- Presenters: Ramo Naidu, MD; Chris Bovinet, DO; Morad Nasseri, MD
- Date: Thursday, January 22, 2026
- Time: 7:30 PM – 8:00 PM
- Venue: NANS Exhibit Hall (Innovation Theater Stage)
- Title: IGNITE: Leading the Clinical Evidence Revolution
- Presenters: Shanth Thiyagalingam; Tim Deer, MD; Dawood Sayed, MD; Jordan Tate, MD, MPH; Leonardo Kapural, MD, PhD
- Date: Friday, January 23, 2026
- Time: 9:00 PM – 10:00 PM
- Venue: Toca Madera Las Vegas
Source link
Leave a Reply